For quite a long time, Christopher P. Austin has been attempting to create a route for science to construct a finer association with patients. Dr. Austin is executive of the National Center for Advancing Translational Sciences (NCATS), a piece of the NIH. NCATS is attempting to discover approaches to get new medicines and cures for ailments conveyed to patients speedier. At NCATS, Dr. Austin heads a state-of-the-workmanship lab that uses robots to scan for medicines. Lately, groups of patients with uncommon maladies have gone to the NIH to watch the robots at work in the $20 million, 30,000 square-foot framework that incorporates iceboxes, computerized hatcheries and machines. Machines work all day and all night, testing a huge number of mixes against a mixture of basically uncommon sicknesses.